Latest biosimilar drugs news
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
posted February 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Wezlana for Multiple Inflammatory Diseases
posted November 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
More Biosimilars Marketed in Germany, Switzerland Than U.S.
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections Monthly Specialist Briefings
Stay Connected
